ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 193 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,988,491 | -15.8% | 112,408 | -12.6% | 0.02% | -15.0% |
| Q2 2023 | $2,362,540 | +32.8% | 128,609 | +36.4% | 0.02% | +25.0% |
| Q1 2023 | $1,779,641 | -8.6% | 94,311 | -15.4% | 0.02% | -11.1% |
| Q4 2022 | $1,947,427 | +5.7% | 111,473 | -3.7% | 0.02% | -51.4% |
| Q3 2022 | $1,842,000 | +11.0% | 115,708 | +20.8% | 0.04% | +42.3% |
| Q2 2022 | $1,660,000 | +55.7% | 95,760 | +66.9% | 0.03% | +73.3% |
| Q1 2022 | $1,066,000 | +80.4% | 57,366 | +70.5% | 0.02% | +87.5% |
| Q4 2021 | $591,000 | +10.3% | 33,638 | +5.7% | 0.01% | -11.1% |
| Q3 2021 | $536,000 | +9.4% | 31,829 | +10.3% | 0.01% | +12.5% |
| Q2 2021 | $490,000 | -1.2% | 28,864 | -4.6% | 0.01% | -20.0% |
| Q1 2021 | $496,000 | -22.6% | 30,261 | -13.8% | 0.01% | -23.1% |
| Q4 2020 | $641,000 | +30.8% | 35,086 | +30.0% | 0.01% | -67.5% |
| Q3 2020 | $490,000 | +21.6% | 26,979 | +14.6% | 0.04% | +8.1% |
| Q2 2020 | $403,000 | +23.2% | 23,537 | +9.1% | 0.04% | -7.5% |
| Q1 2020 | $327,000 | +12.0% | 21,574 | +7.8% | 0.04% | +37.9% |
| Q4 2019 | $292,000 | – | 20,021 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prostatis Group LLC | 500,689 | $7,585,438 | 10.78% |
| Almanack Investment Partners, LLC. | 2,310,779 | $35,008,000 | 7.52% |
| Hudock, Inc. | 959,228 | $14,532,000 | 5.71% |
| SimpliFi, Inc. | 595,575 | $9,023,000 | 5.64% |
| UBP Investment Advisors SA | 405,987 | $6,151,000 | 5.56% |
| Allen Capital Group, LLC | 850,481 | $12,885,000 | 3.97% |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 84,266 | $1,276,000 | 2.98% |
| American Money Management, LLC | 302,921 | $4,589,000 | 2.57% |
| WT Wealth Management | 132,453 | $2,006,000 | 2.11% |
| FormulaFolio Investments, LLC | 2,385,654 | $36,143,000 | 1.93% |